91(1): 2C4C Bellinghieri G, Savica V, Mallamace A, et al
Check Your Eligibility If you want to learn whether GLP-1 treatment is right for you and receive personalized guidance from providers who understand how to optimize your experience, you can start by completing Mochi's eligibility questionnaire
Mechanistic sampling of intestinal tissue during this trial would best validate the reparative hypothesis if analyses include tight junction protein expression (e.g., claudins, occludin, zonula occludens-1), histologic healing assessments using validated indices (e.g., Geboes score, Robarts Histopathology Index), and intestinal permeability assays such as the lactulose-mannitol ratio
Abstract Water quality and hydration are crucial in optimizing athletic performance, particularly for elite swimmers who train in aquatic environments
You might not be looking for a dramatic transformation or chasing a trend, but instead want to understand the science, separate hype from reality, and explore whether lower-dose GLP-1 support could play a role in your long-term metabolic and overall health
However, over the past decade, landmark cardiovascular outcomes trials of sodium-glucose cotransporter type 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) have transformed this paradigm [5,6,7,8,9,10,11]